TABLE 5.

Antioxidant Status of Subjects

Antioxidant biomarkers	Treatment		Placebo		P1	P2	Effect size (Test vs. Placebo)
	Baseline	Week 12	Baseline	Week 12			Cohen's d [SD pooled ]
GSH (µmol/L)	481.50 ± 127.40	528.80 ± 117.80	460.70 ± 123.20	458.00 ± 123.10	>.999	.0242	1.54 [32.52]
MDA (µmol/L)	4.31 ± 0.88	3.50 ± 0.93	4.45 ± 0.87	4.75 ± 0.88	>.999	<.0001	−1.66 [0.66]

Values are means ± SD. P1 = Comparison of mean between the two groups at baseline; P2 = Comparison of mean between the two groups at week 12; Significant differences at p <.05. Cohen's d = baseline‐corrected difference between treatment and placebo means at completion. Bold indicates a large treatment effect, with direction indication by sign.

Abbreviations: GSH, reduced glutathione; MDA, Malondialdehyde.